BliNK Biomedical Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $1.84M

  • Investors
  • 4

BliNK Biomedical General Information

Description

Developer of a B cell technology platform designed to assist in the selection and isolation of specific antibody-producing cells. The company's platform specializes to constitute an efficient and deep mining process that isolates antibody-producing cells for difficult targets from B cells of many species, such as men, mice, rabbits, and dogs, enabling researchers to identify unique therapeutic antibodies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • 17 Boulevard Cieussa
  • 13007 Marseille
  • France
+33 04 00 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BliNK Biomedical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 12-Jul-2016 $1.84M 00.000 Completed Generating Revenue
1. Early Stage VC (Series A) 11-Dec-2014 00.000 00.000 Completed Generating Revenue
To view BliNK Biomedical’s complete valuation and funding history, request access »

BliNK Biomedical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a B cell technology platform designed to assist in the selection and isolation of specific antibody-produci
Biotechnology
Marseille, France
11 As of 2016
00.000
00000000000 00.000

000000

t ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exerci
0000 000000000
Cambridge, MA
00 As of 0000
00000
000000000000 00000

000000

re et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ul
0000 000000000
Schlieren, Switzerland
00 As of 0000
000.00
000.00 0000-00-00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BliNK Biomedical Competitors (80)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
HiFiBiO Therapeutics Venture Capital-Backed Cambridge, MA 00 00000 000000000000 00000
Virometix Venture Capital-Backed Schlieren, Switzerland 00 000.00 00000000000 000.00
Marengo Therapeutics Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
Aviva Systems Biology Formerly VC-backed San Diego, CA 00 000.00 00000000000 000.00
Aurora Biopharma Angel-Backed New York, NY 00000 0000000000 00000
You’re viewing 5 of 80 competitors. Get the full list »

BliNK Biomedical Patents

BliNK Biomedical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3072767-A1 Novel nicotine-binding antibodies Pending 15-Aug-2017 000000000
US-20230089068-A1 Novel nicotine-binding antibodies Pending 15-Aug-2017 000000000
AU-2018317372-A1 Novel nicotine-binding antibodies Pending 15-Aug-2017 000000000
US-20200377616-A1 Novel nicotine-binding antibodies Active 15-Aug-2017 000000000
US-11440970-B2 Nicotine-binding antibodies Active 15-Aug-2017 C07K16/44 00
To view BliNK Biomedical’s complete patent history, request access »

BliNK Biomedical Executive Team (2)

Name Title Board Seat
Jack Elands Ph.D Chief Executive Officer & Chairman
You’re viewing 1 of 2 executive team members. Get the full list »

BliNK Biomedical Board Members (7)

Name Representing Role Since
Franck Grimaud Valneva Board Member 000 0000
Jack Elands Ph.D Self Chief Executive Officer & Chairman 000 0000
Thierry Laugel Ph.D Kurma Partners Board Member 000 0000
You’re viewing 3 of 7 board members. Get the full list »

BliNK Biomedical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BliNK Biomedical Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cancer Research Horizons Venture Capital Minority 000 0000 000000 0
Eurazeo PE/Buyout Minority 000 0000 000000 0
Kurma Partners Venture Capital Minority 000 0000 000000 0
Valneva Corporation Minority 000 0000 000000 0
To view BliNK Biomedical’s complete investors history, request access »

BliNK Biomedical FAQs

  • When was BliNK Biomedical founded?

    BliNK Biomedical was founded in 2014.

  • Who is the CEO of BliNK Biomedical?

    Jack Elands Ph.D is the CEO of BliNK Biomedical.

  • Where is BliNK Biomedical headquartered?

    BliNK Biomedical is headquartered in Marseille, France.

  • What is the size of BliNK Biomedical?

    BliNK Biomedical has 11 total employees.

  • What industry is BliNK Biomedical in?

    BliNK Biomedical’s primary industry is Biotechnology.

  • Is BliNK Biomedical a private or public company?

    BliNK Biomedical is a Private company.

  • What is BliNK Biomedical’s current revenue?

    The current revenue for BliNK Biomedical is 000000.

  • How much funding has BliNK Biomedical raised over time?

    BliNK Biomedical has raised $6.81M.

  • Who are BliNK Biomedical’s investors?

    Cancer Research Horizons, Eurazeo, Kurma Partners, and Valneva have invested in BliNK Biomedical.

  • Who are BliNK Biomedical’s competitors?

    HiFiBiO Therapeutics, Virometix, Marengo Therapeutics, Aviva Systems Biology, and Aurora Biopharma are some of the 80 competitors of BliNK Biomedical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »